Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

16 May 2013: Cisco Named UCL Enterprise Corporate Partner of the Year 2013

Cisco is recognised for the length – and breadth – of their relationship with UCL. It’s origins lie with Prof Peter Kirstein in Computer Science over 30 years ago and that commitment is reflected today by the efforts of Prof Anthony Finkelstein, Dean of Engineering.
More...

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>